Shirakami Y - Search Results

1

Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.

Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Watabe T, Ooe K, Yin X, Haba H, Shirasaki K, Kikunaga H, Tsukada K, Toyoshima A, Cardinale J, Giesel FL, Fukase K. Kaneda-Nakashima K, et al. Among authors: shirakami y. Int J Mol Sci. 2024 Jan 11;25(2):933. doi: 10.3390/ijms25020933. Int J Mol Sci. 2024. PMID: 38256007 Free PMC article.

2

Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.

Oka S, Okudaira H, Ono M, Schuster DM, Goodman MM, Kawai K, Shirakami Y. Oka S, et al. Among authors: shirakami y. Mol Imaging Biol. 2014 Jun;16(3):322-9. doi: 10.1007/s11307-013-0693-0. Mol Imaging Biol. 2014. PMID: 24136390

3

[Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells].

Minosako Y, Nemoto M, Ino S, Shirakami Y, Kurami M. Minosako Y, et al. Among authors: shirakami y. Kaku Igaku. 2003 Feb;40(1):23-30. Kaku Igaku. 2003. PMID: 12701204 Japanese.

4

Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings.

Doi Y, Kanagawa M, Maya Y, Tanaka A, Oka S, Nakata N, Toyama M, Matsumoto H, Shirakami Y. Doi Y, et al. Among authors: shirakami y. Nucl Med Biol. 2015 Aug;42(8):664-72. doi: 10.1016/j.nucmedbio.2015.04.008. Epub 2015 May 7. Nucl Med Biol. 2015. PMID: 26022202

5

Enhancement of ²¹¹At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer.

Watabe T, Kaneda-Nakashima K, Liu Y, Shirakami Y, Ooe K, Toyoshima A, Shimosegawa E, Fukuda M, Shinohara A, Hatazawa J. Watabe T, et al. Among authors: shirakami y. J Nucl Med. 2019 Sep;60(9):1301-1307. doi: 10.2967/jnumed.118.222638. Epub 2019 Feb 22. J Nucl Med. 2019. PMID: 30796173 Free PMC article.

6

Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: ⁶⁴Cu- and ²²⁵Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.

Watabe T, Liu Y, Kaneda-Nakashima K, Shirakami Y, Lindner T, Ooe K, Toyoshima A, Nagata K, Shimosegawa E, Haberkorn U, Kratochwil C, Shinohara A, Giesel F, Hatazawa J. Watabe T, et al. Among authors: shirakami y. J Nucl Med. 2020 Apr;61(4):563-569. doi: 10.2967/jnumed.119.233122. Epub 2019 Oct 4. J Nucl Med. 2020. PMID: 31586001 Free PMC article.

7

Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [²¹¹At] NaAt in Mice: A Revisit.

Liu Y, Watabe T, Kaneda-Nakashima K, Ooe K, Shirakami Y, Toyoshima A, Shimosegawa E, Nakano T, Shinohara A, Hatazawa J. Liu Y, et al. Among authors: shirakami y. Transl Oncol. 2020 Apr;13(4):100757. doi: 10.1016/j.tranon.2020.100757. Epub 2020 Mar 25. Transl Oncol. 2020. PMID: 32220762 Free PMC article.

8

Targeted alpha therapy using astatine (²¹¹At)-labeled phenylalanine: A preclinical study in glioma bearing mice.

Watabe T, Kaneda-Nakashima K, Shirakami Y, Liu Y, Ooe K, Teramoto T, Toyoshima A, Shimosegawa E, Nakano T, Kanai Y, Shinohara A, Hatazawa J. Watabe T, et al. Among authors: shirakami y. Oncotarget. 2020 Apr 14;11(15):1388-1398. doi: 10.18632/oncotarget.27552. eCollection 2020 Apr 14. Oncotarget. 2020. PMID: 32341757 Free PMC article.

9

Development of high-resolution YAP(Ce) x-ray camera for the imaging of astatine-211(At-211) in small animals.

Nakanishi K, Yamamoto S, Watabe T, Kaneda-Nakashima K, Shirakami Y, Ooe K, Toyoshima A, Shinohara A, Teramoto T, Hatazawa J, Kamada K, Yoshikawa A. Nakanishi K, et al. Among authors: shirakami y. Med Phys. 2020 Nov;47(11):5739-5748. doi: 10.1002/mp.14455. Epub 2020 Sep 22. Med Phys. 2020. PMID: 32916769

10

α-Emitting cancer therapy using ²¹¹ At-AAMT targeting LAT1.

Kaneda-Nakashima K, Zhang Z, Manabe Y, Shimoyama A, Kabayama K, Watabe T, Kanai Y, Ooe K, Toyoshima A, Shirakami Y, Yoshimura T, Fukuda M, Hatazawa J, Nakano T, Fukase K, Shinohara A. Kaneda-Nakashima K, et al. Among authors: shirakami y. Cancer Sci. 2021 Mar;112(3):1132-1140. doi: 10.1111/cas.14761. Epub 2021 Jan 22. Cancer Sci. 2021. PMID: 33277750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page